Respiration is controlled by both the involuntary and voluntary nervous systems. Involuntary control, which governs automatic breathing, is managed by the respiratory centers in the brainstem (medulla oblongata and pons), which respond to blood levels of oxygen, carbon dioxide, and pH. Voluntary control comes from the cerebral cortex and allows you to control your breathing for activities like speaking or holding your breath.
Overall Objective: To understand the neural pathways and chemical factors that regulate the rate and depth of breathing, ensuring appropriate gas exchange to meet metabolic demands and maintain blood gas homeostasis.
Objective 1: Identify and describe the key neural control centers for respiration in the brainstem.
The control of breathing is a complex process involving both voluntary and involuntary mechanisms. The involuntary, rhythmic control of breathing primarily originates in the brainstem, specifically in the medulla oblongata and the pons. These areas contain specialized groups of neurons that generate and modulate the respiratory rhythm.
The medulla oblongata houses the most crucial respiratory control centers, responsible for setting the basic rhythm of breathing. These are broadly divided into two main groups: the Dorsal Respiratory Group (DRG) and the Ventral Respiratory Group (VRG).
Located in the posterior portion of the medulla, near the nucleus of the tractus solitarius.
The DRG is the most fundamental and active group involved in controlling the basic rhythm of breathing, especially during quiet (eupneic) respiration. It primarily controls inspiration.
Receives sensory input (afferent signals) from:
This sensory input allows the DRG to modify the basic respiratory rhythm in response to physiological demands.
Located in the anterior portion of the medulla, extending from the brainstem to the upper spinal cord, including the pre-Bötzinger complex.
The VRG is largely inactive during quiet breathing. It becomes active and crucial for generating the respiratory rhythm only when there is an increased ventilatory demand, such as during forceful (active) inspiration and expiration.
Contains both inspiratory and expiratory neurons.
Current research suggests that a small area within the VRG, known as the pre-Bötzinger complex, is the primary site responsible for generating the basic respiratory rhythm. It acts as the pacemaker for breathing, relaying signals to the DRG.
During exercise or respiratory distress, the DRG activates the VRG. The VRG then significantly increases the strength of both inspiratory and expiratory signals, leading to a deeper and more rapid breathing pattern.
The pons contains centers that modify and fine-tune the activity of the medullary respiratory centers, ensuring smooth transitions between inspiration and expiration. These are often collectively referred to as the Pontine Respiratory Group (PRG) and include the Pneumotaxic and Apneustic centers.
Upper Pons (Nucleus Parabrachialis)
Primary Function: Primarily acts to limit inspiration and fine-tune the respiratory rate. It essentially "switches off" the inspiratory ramp signal from the DRG.
Clinical Significance: Damage to this center can lead to prolonged inspiration and decreased respiratory rate.
Lower Pons
Primary Function: Has an excitatory effect on the medullary inspiratory neurons, particularly the DRG. It essentially prolongs inspiration.
Interaction with Pneumotaxic Center: Normally, the pneumotaxic center overrides the apneustic center, preventing prolonged inspiration and ensuring rhythmic breathing.
Clinical Significance: Damage to the pneumotaxic center or vagal nerves (which also inhibit inspiration) can allow the apneustic center to dominate, leading to apneustic breathing.
This intricate interplay of neural centers ensures that breathing is a continuous, rhythmic process that can be finely adjusted to meet the body's changing metabolic demands.
Objective 2: Explain the roles of central chemoreceptors in regulating breathing.
The chemical control of respiration is paramount for maintaining arterial blood gas homeostasis (PCO2, PO2, and pH). Chemoreceptors are specialized sensory receptors that detect changes in the chemical composition of the blood and cerebrospinal fluid (CSF) and send signals to the respiratory centers in the brainstem to adjust ventilation accordingly.
Central chemoreceptors are the most potent and important regulators of ventilation under normal physiological conditions.
Primary Location: Strategically located in the ventrolateral surface of the medulla oblongata, very close to the DRG and VRG respiratory centers. This proximity allows for a rapid and direct influence on breathing patterns.
(Largely driven by arterial PCO2)
Not directly sensitive to blood CO2: Central chemoreceptors are not directly sensitive to changes in arterial PCO2, but rather to the pH of the cerebrospinal fluid (CSF).
Unlike H+ and HCO3- ions, CO2 is lipid-soluble and readily diffuses across the blood-brain barrier from the systemic circulation into the CSF.
Once in the CSF, CO2 reacts with water to form carbonic acid (H2CO3), a reaction facilitated by carbonic anhydrase (though less prevalent than in RBCs, it still occurs spontaneously).
The CSF has a very low protein concentration, meaning it has a much weaker buffering capacity compared to blood plasma. Therefore, even small changes in CO2 entering the CSF can cause a significant change in CSF H+ concentration, and thus, a notable change in CSF pH.
It is these increased H+ ions (decreased pH) in the CSF that directly stimulate the central chemoreceptors.
Increased arterial PCO2 → Increased CO2 in CSF → Increased H+ in CSF → Decreased CSF pH → Stimulation of central chemoreceptors → Increased ventilation.
Decreased arterial PCO2 → Decreased CO2 in CSF → Decreased H+ in CSF → Increased CSF pH → Inhibition of central chemoreceptors → Decreased ventilation.
Dominant Regulator: Under normal physiological conditions, arterial PCO2 (and thus CSF pH) is the most powerful and closely regulated chemical stimulus for breathing. Even small changes in PCO2 (e.g., a 1-2 mmHg increase) can significantly alter ventilation.
Central chemoreceptors respond quickly (within seconds to minutes) to acute changes in PCO2, causing a robust increase in ventilation.
If high PCO2 levels persist for several days, the kidneys compensate by retaining bicarbonate ions (HCO3-) in the blood. These HCO3- ions eventually diffuse into the CSF, buffering the excess H+ ions. This "normalizes" the CSF pH, even though arterial PCO2 remains high.
In such patients, the central chemoreceptors become desensitized or "reset" to the chronically high PCO2. Their primary respiratory drive then shifts from PCO2 to the hypoxic drive (detected by peripheral chemoreceptors).
This is why oxygen administration in COPD patients needs to be carefully monitored and typically delivered at lower flow rates.
Insensitivity to Hypoxia: Central chemoreceptors are essentially insensitive to changes in arterial PO2. This role is primarily handled by the peripheral chemoreceptors.
In essence, central chemoreceptors are the body's primary "CO2 sensors," indirectly monitoring arterial CO2 levels by sensing CSF pH, and they are crucial for maintaining CO2 homeostasis.
Objective 3: Explain the roles of peripheral chemoreceptors in regulating breathing.
Peripheral chemoreceptors provide an additional layer of chemical control, primarily acting as the body's emergency sensors for oxygen levels and as a secondary sensor for CO2 and pH.
These are specialized sensory organs located in specific arteries outside the brain.
Location: Small, highly vascularized structures located bilaterally at the bifurcation of the common carotid arteries (where they split into internal and external carotid arteries).
Innervation: Send afferent (sensory) signals to the medulla oblongata via the glossopharyngeal nerve (CN IX).
Significance: Because they sample blood going to the brain, they are particularly important for ensuring adequate oxygen supply to the brain.
Location: Scattered along the aortic arch.
Innervation: Send afferent signals to the medulla oblongata via the vagus nerve (CN X).
Significance: Monitor the arterial blood that will be distributed to the rest of the body.
Oxygen Sensitivity: Peripheral chemoreceptors are the body's primary and most important sensors for detecting changes in arterial oxygen levels.
They are relatively insensitive to changes in PO2 until arterial PO2 falls below a critical threshold, typically around 60-70 mmHg.
Below this level, their firing rate increases sharply and exponentially. This means they act more as an "emergency" oxygen sensor rather than a fine-tuner of normal PO2.
This corresponds to the steep part of the oxygen-hemoglobin dissociation curve. Below this point, a small drop in PO2 leads to a significant decrease in hemoglobin saturation and oxygen content, which could rapidly become life-threatening.
Response to Hypoxia: When activated by low PO2, they send strong excitatory signals to the DRG, leading to a significant increase in ventilation (hyperventilation).
While central chemoreceptors are the dominant sensors for PCO2, peripheral chemoreceptors also respond to increases in arterial PCO2.
Their response to CO2 is faster but quantitatively less powerful (about 20-30%) than that of the central chemoreceptors. This means they contribute to the overall ventilatory response to hypercapnia, particularly in its initial, acute phase.
Peripheral chemoreceptors are directly sensitive to changes in arterial H+ concentration (pH), independent of PCO2.
This is especially important in metabolic acidosis (e.g., diabetic ketoacidosis), where H+ levels rise without a primary increase in PCO2. In such cases, the peripheral chemoreceptors are crucial for stimulating hyperventilation to "blow off" CO2, thereby attempting to raise blood pH.
Hypoxic Drive: As mentioned in our previous discussion on central chemoreceptors, in individuals with chronic hypercapnia (e.g., severe COPD), the central chemoreceptors become desensitized to high PCO2. In these patients, the hypoxic drive (stimulation of peripheral chemoreceptors by low PO2) becomes the primary stimulus for breathing.
If a COPD patient with chronic hypercapnia is given high concentrations of supplemental oxygen, their arterial PO2 rises significantly. This rise in PO2 removes the hypoxic stimulus from the peripheral chemoreceptors, thus diminishing their main remaining drive to breathe.
This can lead to severe hypoventilation, worsening hypercapnia, respiratory acidosis, and potentially coma or death. Therefore, oxygen therapy in these patients must be carefully managed to avoid suppressing their crucial hypoxic drive.
The peripheral chemoreceptors are vital for triggering a rapid ventilatory response to acute hypoxemia (e.g., at high altitude, during suffocation).
They are the sole chemoreceptors to respond to changes in pH that are not caused by changes in PCO2 (i.e., metabolic acidosis), driving the compensatory hyperventilation (Kussmaul breathing) seen in conditions like diabetic ketoacidosis.
Objective 4: Describe the various lung and airway receptors that influence breathing.
Beyond the central control in the brainstem and chemical feedback from chemoreceptors, a variety of mechanoreceptors and irritant receptors located within the lungs and airways provide sensory input that modifies the breathing pattern. These receptors relay information predominantly via the vagus nerves (CN X) to the medullary respiratory centers.
Mechanism: When these receptors are significantly stimulated (i.e., during deep inspiration, or in infants even during normal inspiration), they send inhibitory signals to the inspiratory neurons of the DRG.
Effect: This inhibition terminates inspiration and therefore prolongs the expiratory phase. It acts as a protective mechanism to prevent overinflation of the lungs, particularly important in newborns and during exercise in adults. In resting adults, it may not play a major role until tidal volume exceeds approximately 1.5 liters.
Adaptation: They are "slowly adapting" because they continue to fire as long as the stretch is maintained.
Adaptation: They are "rapidly adapting" because they respond vigorously to the onset of a stimulus but then quickly decrease their firing rate even if the stimulus persists.
| Receptor Type | Function/Reflex |
|---|---|
| Pulmonary Stretch | Prevent overinflation, modulate inspiratory duration (Hering-Breuer). |
| Irritant | Protect airways from noxious stimuli, trigger cough/bronchoconstriction. |
| J-Receptors | Respond to interstitial fluid changes, contribute to dyspnea and rapid shallow breathing. |
These receptors act as sophisticated sensors within the respiratory system, providing essential feedback to the brain to adjust ventilation and activate protective reflexes, ensuring both efficient gas exchange and the integrity of the airways.
Objective 5: Identify other factors that influence respiratory control.
Beyond the primary medullary and pontine centers, chemoreceptors, and pulmonary reflexes, several other physiological and psychological factors can exert significant influence over the rate and depth of respiration. These often involve higher brain centers or specialized sensory receptors throughout the body.
Mechanism: The cerebral cortex, particularly the motor cortex, can temporarily override the brainstem's automatic respiratory centers. This allows for conscious control over breathing.
This voluntary control is ultimately limited. If CO2 levels rise too high (or O2 levels fall too low) during breath-holding, the involuntary drive from the medullary centers (primarily via central chemoreceptors sensing CO2) will eventually become so strong that it overrides voluntary inhibition, forcing a breath.
Mechanism: The hypothalamus, a key brain region for regulating homeostatic functions and emotional responses, can influence the respiratory centers.
Strong emotions (e.g., fear, anxiety, anger, excitement) can cause changes in breathing patterns (e.g., gasping, hyperventilation, sighing). Mediated by pathways from the limbic system to the hypothalamus.
Sudden severe pain often causes a brief period of apnea followed by rapid, shallow breathing. Prolonged pain typically leads to an increase in respiratory rate.
Location: Sensory receptors located in muscles, tendons, and joints throughout the body.
When movement begins (e.g., at the start of exercise), these proprioceptors send excitatory signals to the medullary respiratory centers, causing an immediate increase in ventilation. This anticipatory response ensures that ventilation increases before there are significant changes in blood gases or pH due to increased metabolic activity.
Significance: This "neurogenic drive" is a significant contributor to the rapid increase in breathing observed at the onset of exercise.
Location: Carotid sinuses and aortic arch.
Significance: Plays a role in integrated cardiovascular/respiratory homeostasis, though less powerful than chemoreceptors.
Receptors: Free nerve endings in nose, pharynx, larynx, trachea.
Reflexes: Sneezing, coughing, bronchoconstriction, temporary apnea. Similar to lung irritant receptors but specific to the upper tract.
These diverse influences demonstrate that respiration is not merely an automatic process driven by basic chemical needs, but a highly adaptable system integrated with our emotional state, physical activity, and protective reflexes.
Objective 6: Explain how the body responds to changes in PCO2, PO2, and pH to maintain respiratory homeostasis.
The respiratory system works tirelessly to maintain arterial partial pressures of carbon dioxide (PCO2) and oxygen (PO2), and arterial pH within very narrow physiological limits. This is achieved through a sophisticated negative feedback system involving chemoreceptors and medullary respiratory centers.
Definition: Hypercapnia is an abnormally high level of CO2 in the arterial blood (PaCO2 > 45 mmHg). It typically occurs due to hypoventilation (inadequate removal of CO2).
Increased PaCO2 readily diffuses across the blood-brain barrier into the CSF. In the CSF, CO2 is converted to H+, leading to a decrease in CSF pH. This decreased CSF pH strongly stimulates the central chemoreceptors in the medulla.
Increased PaCO2 also directly stimulates the peripheral chemoreceptors (carotid and aortic bodies). This response is faster but less powerful than the central chemoreceptor response to CO2.
Summary: Increased PaCO2 is the most powerful ventilatory stimulus. A rise of just 1-2 mmHg in PaCO2 can double ventilation.
Definition: Hypoxemia is an abnormally low level of O2 in the arterial blood (PaO2 < 80 mmHg).
Summary: Decreased PaO2 is a potent ventilatory stimulus, but only when it falls significantly below normal levels. It acts primarily as an emergency mechanism.
Definition: Acidosis (pH < 7.35) or alkalosis (pH > 7.45) refers to an imbalance in arterial blood pH.
Decreased pH, Normal/Decreased PaCO2
Primary Role: Peripheral chemoreceptors are directly sensitive to increased H+.
Secondary Role: Central chemoreceptors play a delayed, indirect role if acidosis is prolonged.
Outcome: Marked increase in ventilation (hyperventilation), often characterized by deep, rapid breaths known as Kussmaul respiration.
Restoration: "Blowing off" CO2 reduces H+ concentration, raising pH back toward normal.
Increased pH, Normal/Increased PaCO2
Primary Role: Decreased H+ (increased pH) inhibits peripheral chemoreceptors.
Outcome: Decreased ventilation (hypoventilation).
Restoration: Hypoventilation leads to CO2 retention, increasing H+ concentration and lowering pH back toward normal.
Objective 7: Identify and describe common abnormal breathing patterns and their physiological basis.
Understanding normal quiet breathing (eupnea) is essential, but equally important is the ability to recognize and interpret deviations from this pattern.
Quiet, effortless, rhythmic breathing (12-20 breaths/min). Generated by medullary centers maintaining homeostasis.
Cessation of breathing.
Subjective sensation of "shortness of breath." Complex sensation involving increased effort, ventilatory demand mismatch, and chemoreceptor stimulation. Common in heart failure, COPD, anxiety.
Rapid breathing (>20/min). Caused by acidosis, hypoxemia, fever, anxiety, pain.
Slow breathing (<12/min). Caused by CNS depression (opioids), hypothermia, metabolic alkalosis.
Hyperpnea: Increased depth/rate to meet metabolic demand (exercise, altitude).
Kussmaul: Deep, rapid, labored breathing. Specific compensatory mechanism for severe metabolic acidosis (DKA) to blow off CO2.
Cyclical pattern: gradual increase in volume/rate, then decrease, then apnea. Repeats.
Irregular shallow breaths followed by irregular apnea. Indicates severe medullary damage (stroke, trauma). Pre-terminal.
Prolonged inspiratory pauses, short expirations. Indicates pontine damage disrupting the pneumotaxic center.
Test your knowledge with these 30 questions.
Question 1/30
Here are your results, .
Your Score
27/30
90%